<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03172390</url>
  </required_header>
  <id_info>
    <org_study_id>1708028</org_study_id>
    <secondary_id>2017-A00871-52</secondary_id>
    <nct_id>NCT03172390</nct_id>
  </id_info>
  <brief_title>In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance</brief_title>
  <official_title>In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ascending aorta aneurysmal disease is common and can be complicated by dissection or rupture.&#xD;
      There is substantial variation in individual aneurysm progression: established risk factors&#xD;
      for an accelerated aneurysm growth rate include initial size or localization, the presence of&#xD;
      aortic valve disease, congenital bicuspid aortic valve or connective tissue disorders.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although there is an increased lifetime risk when the aortic diameter exceeds 6 cm,&#xD;
      predicting aneurysm progression is nearly impossible and dissection and rupture also occur at&#xD;
      diameters under 6 cm. The assessment of aortic hemodynamics and the presence of altered flow&#xD;
      patterns, as well as distribution and changes in wall shear stress (WSS) and the oscillatory&#xD;
      shear index (OSI), using 4D phase contrast cardiovascular magnetic resonance (CMR) may&#xD;
      provide further insights in how aneurysms develop and in assessing the risk of dissection.&#xD;
      The purpose of this study was to investigate in patients with dilated ascending aorta the&#xD;
      flow patterns and vessel wall parameters in order to correlate these hemodynamics factors&#xD;
      with changes in aorta size.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 11, 2017</start_date>
  <completion_date type="Actual">March 4, 2020</completion_date>
  <primary_completion_date type="Actual">April 11, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective cohort</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between wall shear stress (WSS) and aorta diameter in patient with dilated ascending aorta</measure>
    <time_frame>From baseline to 1 year</time_frame>
    <description>Aorta diameter [mm] is assessed by 4D phase contrast cardiovascular magnetic resonance (CMR) Wall shear stress (WSS) in aorta [Pa] is assessed by 4D phase contrast cardiovascular magnetic resonance (CMR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aorta parameters associated with change in aorta diameter</measure>
    <time_frame>From baseline to 1 year</time_frame>
    <description>Aorta parameters are a composite outcome :&#xD;
the oscillatory shear index (OSI)&#xD;
pulse wave velocity=PWV [m/s] assessed by 4D phase contrast cardiovascular magnetic resonance (CMR). Aorta diameter [mm] is assessed by 4D phase contrast cardiovascular magnetic resonance (CMR)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Aortic Rupture</condition>
  <arm_group>
    <arm_group_label>Cohort of patients : ascending aorta dilatation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>measure of ascending aorta quality and quantity parameters by 4D Cardiac magnetic resonance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>4D Cardiac Magnetic Resonance</intervention_name>
    <description>4D Cardiac Magnetic Resonance for patients with a ascending aorta dilatation without current indication for surgery for measured parameters of ascending aorta</description>
    <arm_group_label>Cohort of patients : ascending aorta dilatation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years.&#xD;
&#xD;
          -  Supra-coronary aortic diameter measured by CT-scan or transthoracic/trans-esophageal&#xD;
             echocardiography between 40 and 45 mm in case of presence of aortic valve disease,&#xD;
             bicuspid aortic valve or connective tissue disease and between 40 and 50 mm in case of&#xD;
             absence of aortic valve disease, bicuspid aortic valve disease or connective tissue.&#xD;
&#xD;
          -  Informed consent for participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to MRI&#xD;
&#xD;
          -  Patient's refusal to participate in the study and / or inability to express agreement&#xD;
             or signing the informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Saint-Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <state>Loire</state>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 23, 2017</study_first_submitted>
  <study_first_submitted_qc>May 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2017</study_first_posted>
  <last_update_submitted>November 12, 2020</last_update_submitted>
  <last_update_submitted_qc>November 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ascending aorta aneurysm</keyword>
  <keyword>Aortic wall shear stress</keyword>
  <keyword>4D phase contrast Cardiovascular Magnetic Resonance</keyword>
  <keyword>Aortic dissection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Rupture</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

